Literature DB >> 1311924

Cloning and increased expression of an insulin receptor substrate-1-like gene in human hepatocellular carcinoma.

M Nishiyama1, J R Wands.   

Abstract

Human insulin receptor substrate-1 (hIRS-1) cDNAs were cloned from a lambda GT11 expression library using a monoclonal antibody (MAb) produced against a human hepatocellular carcinoma (HCC) cell line (FOCUS). The predicted amino acid sequence derived from both a genomic DNA fragment and the cDNAs showed a 90.5% identity to the previously reported rat IRS-1 cDNA [Sun, X.P. (1991) Nature 352, 73-77]. Multiple potential phosphorylation sites, that suggest an intrinsic function of this molecule in response to insulin action, were highly conserved between the two species. A c.a. 180 kDa hIRS-1 protein was immunoprecipitated and found to be phosphorylated on tyrosine residue(s) following insulin stimulation of HuH-7 HCC cells. Northern blot analysis demonstrated a single c.a. 5 kb transcript in HCC cell lines and tissues. Higher levels of hIRS-1 gene transcripts were observed in HCC tumors compared to adjacent non-involved normal liver.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311924     DOI: 10.1016/0006-291x(92)91640-c

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the alpha6beta4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion.

Authors:  L M Shaw
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype.

Authors:  S Tanaka; J R Wands
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

3.  A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.

Authors:  Arihiro Aihara; Chiung-Kuei Huang; Mark J Olsen; Qiushi Lin; Waihong Chung; Qi Tang; Xiaoqun Dong; Jack R Wands
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

4.  Overexpression of insulin receptor substrate-1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis.

Authors:  D Nehrbass; F Klimek; P Bannasch
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

5.  Activation of signal transduction pathways during hepatic oncogenesis.

Authors:  Waihong Chung; Miran Kim; Suzanne de la Monte; Lisa Longato; Rolf Carlson; Betty L Slagle; Xiaoqun Dong; Jack R Wands
Journal:  Cancer Lett       Date:  2015-10-01       Impact factor: 8.679

6.  Ethanol inhibits insulin receptor substrate-1 tyrosine phosphorylation and insulin-stimulated neuronal thread protein gene expression.

Authors:  Y Y Xu; K Bhavani; J R Wands; S M de la Monte
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.

Authors:  K Almind; G Inoue; O Pedersen; C R Kahn
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

Review 8.  Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.

Authors:  Kai Breuhahn; Peter Schirmacher
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.

Authors:  M Laakso; M Malkki; P Kekäläinen; J Kuusisto; S S Deeb
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

10.  Identification of two novel amino acid polymorphisms in beta-cell/liver (GLUT2) glucose transporter in Japanese subjects.

Authors:  F Shimada; H Makino; H Iwaoka; S Miyamoto; N Hashimoto; A Kanatsuka; G I Bell; S Yoshida
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.